Our Blog

Business Interruption Insurance Claims and the Coronavirus Epidemic: Round 3 Louisiana, Pennsylvania Lawmakers Introduce COVID-19 Business Interruption Insurance Bills As we noted in an earlier post, some state legislatures are considering proposed laws that would require insurers to cover business interruption insurance claims brought about by civil government mandatory business closing or restriction orders due to the COVID-19 epidemic. We have since learned that two more states, Louisiana and Pennsylvania, are also considering such legislation. In today’s post, the business…

If You’re a Zantac User, Protect Your Health – And Your Legal Rights The U.S. Food and Drug Administration (FDA) took the extraordinary step in March of immediately ordering the removal of over-the-counter Zantac and its prescription counterpart from shelves. Consumers have been directed to stop using Zantac immediately. The FDA announced that it is possible that a dose of Zantac (both the over-the-counter and prescription versions of the product) may contain over 3,000-times the limit of a substance called…

Southern Illinois University Fraternity Busted for Violating Statewide Social Gatherings Ban As we commented in a previous post, the COVID-19 epidemic has led to a virtual shutdown of the nation’s higher educational system. However, it appears that some students didn’t get the message, as the following news item suggest. *** According to a story first carried by the Southern Illinoisan, the Southern Illinois University at Carbondale chapter of the Delta Chi fraternity has been suspended “immediately and indefinitely” after it…

The Food and drug Administration has issued a voluntary recall order affecting the popular stomach acid blocker ranitidine (“Zantac”) after the drug was found to contain the known cancer-causing substance NDMA. In today’s post our dangerous drugs lawyer explains how this recall could lead to hundreds of dangerous/defective drug lawsuits filed by those who developed cancer after taking Zantac.

FDA Orders Leading Heartburn Medication Zantac Immediately Pulled from Market Citing Cancer Danger The U.S. Food and Drug Administration, FDA, took the rare and dramatic step of immediately ordering the widely used heartburn medicine Zantac removed from the market on April 1, 2020. Zantac is the brand name for ranitidine, the primary element of both prescription and over-the-counter versions of this medication. In addition, all generic forms of this drug were ordered off the market by the FDA as well….